Douglas Flora: What a great paper by Dr. Jeanne Kowalski on PACMIDS
Douglas Flora posted on LinkedIn:
“What a great and important paper. Thank you to Dr. Jeanne Kowalski and her collaborators for this huge lift. The shift towards digital systems isn’t just about adopting new tech—it’s a comprehensive transformation. We’re redefining operations, integrating existing resources like databases and public data, and preparing for AI. This creative digital foundation enhances efficiency, fosters innovation, and ensures agility in a landscape of complex research questions and sophisticated analyses.
By merging new and established markers with therapeutic relevance, the authors have created a comprehensive molecular data fabric, including canonical and noncanonical DNA, for seamless AI integration. This data fabric enables personalized, AI-augmented CTDS systems through patient-specific computational workflows. This brilliant initiative culminates in a personalized care model driven by a cohesive molecular treatment data fabric. This sets the stage for effective AI integration and highlights a really progressive approach to AI in precision oncology.
Reach out here to Dr. Kowalski if you’d like to hear more about her team’s work (and ask her about this cool cover art; there is a story.)”
View the article attached to the post.
Source: Douglas Flora/LinkedIn
Dr. Douglas Flora, MD, is a medical oncologist based in Edgewood, Kentucky, with over 24 years of dedicated service in the field. Graduating from the Ohio State University College of Medicine in 1999, Dr. Flora has since become a respected figure in oncology, affiliated with leading hospitals such as St. Elizabeth Healthcare Edgewood-Covington Hospitals and St. Elizabeth Fort Thomas Hospital.
With a background in hematology and medical oncology, Dr. Flora serves as the Chief of the Division of Medical Oncology and Hematology at the TriHealth Cancer Institute in Cincinnati, Ohio. He specializes in treating various cancers, including breast, lung, and gastrointestinal malignancies, utilizing innovative treatment approaches backed by clinical research.
Beyond patient care, Dr. Flora is dedicated to medical education, mentoring future oncologists and contributing to research initiatives aimed at improving patient outcomes. His commitment to excellence and compassionate care underscores his significant impact in the fight against cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023